Pricing Log in Create free account
Saturday 17 October 2026 Export JNJ’s income statement to Excel — free account

Johnson & Johnson

JNJ Healthcare Drug Manufacturers General

Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.

255.55 2.27 +0.90%
Market cap
$610.4B
P/E
29.6×
Fwd P/E
24.9×
Dividend yield
2.07%
F-score
3/9
Altman Z
4.78
Beneish M
−2.26
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Johnson & Johnson (JNJ) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Johnson & Johnson (JNJ) trades at a P/B ratio of 7.2×. Over the past ten years it has ranged from 3.5× (August 2015) to 7.9× (September 2026); the current reading is higher than 98% of that period. That is above the Drug Manufacturers General industry median of 5.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.1× 25.46%
FY2024 4.9× (17.36%)
FY2023 5.9× (3.24%)
FY2022 6.1× 0.13%
FY2021 6.1× (7.10%)
FY2020 6.5× 0.93%
FY2019 6.5× 12.03%
FY2018 5.8× (7.04%)
FY2017 6.2× 42.98%
FY2016 4.4× 9.51%

Quarterly newest first

Period P/B ratio Change
Sep 2026 7.5× 4.24%
Jun 2026 7.2× (0.78%)
Mar 2026 7.3× 18.70%
Dec 2025 6.1× 8.47%
43 more quarters

Against its own ten years

Low 3.5× High 7.9×
Ten-year median 5.7×
Current reading's percentile 97

P/B ratio against peers

Company P/B ratio
ABBV AbbVie Inc. compare n/m
PFE Pfizer Inc. compare 2.0×
AZN AstraZeneca PLC compare 5.1×
NVS Novartis AG compare 6.8×
JNJ Johnson & Johnson 7.2×
MRK Merck & Co., Inc. compare 8.6×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
LLY Eli Lilly and Company compare 33.1×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on JNJ